NCR2 and Miyoshi myopathy: Immunosurveillance against MM onset and progression is actively mediated by NK cells, and among the activating receptors responsible for NK cell recognition and killing of MM cells, the most relevant are NKG2D, DNAM-1, and the NCRs (NKp46, NKp30, NKp44) [28–30].